Skip to main content
An official website of the United States government

site specific immunomodulator QBECO

A formulation composed of components of the inactivated bacteria Escherichia coli (E. coli), with potential immunomodulating activity. Upon subcutaneous administration, site specific immunomodulator (SSI) QBECO stimulates the innate immune system by recruiting and activating M1 macrophages. This may restore the unhealthy and altered gut microbiome, restore the function in the gastrointestinal (GI) tact, restore the immune system and rebuild normal barrier function. In addition, by enhancing and optimizing immune function, cancer cell proliferation may be inhibited and GI tract-related inflammatory diseases may be treated.
Synonym:E. coli-based formulation QBECO
SSI QBECO
Code name:QBECO
Search NCI's Drug Dictionary